Seeking a phage-based therapy to control otitis media by Silva, Maria Daniela & Sillankorva, Sanna
Seeking a phage-based therapy to control otitis media 
Maria Daniela Silva1 and Sanna Sillankorva2 
1CEB – Centre of Biological Engineering, LIBRO – Laboratório de Investigação em Biofilmes 
Rosário Oliveira, University of Minho, 4710-057 Braga, Portugal; 
2INL - International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga, 4715-330 Braga, 
Portugal; sanna.sillankorva@inl.pt 
 
Otitis media is a common paediatric infection of the middle ear and the most common reason for 
which systemic antibiotics are prescribed in children. Streptococcus pneumoniae, Haemophilus 
influenzae and Moraxella catarrhalis are the most frequent bacteria identified in the middle ear fluid 
of children with otitis media. Current oral antibiotic therapy might be ineffective in the treatment of 
biofilms involved in this condition and encourages selection of antimicrobial resistant bacteria, 
contributing to the frequent recurrence and/or chronicity of the disease. Thus, the development of 
novel and alternative strategies for the treatment of otitis media is needed. Bacteriophages and their 
derived enzymes have shown promising antimicrobial effects against infectious diseases and their 
use against S. pneumoniae has been addressed in a few studies, nonetheless no study reports the use 
of virulent phages or endolysins against H. influenzae and M. catarrhalis. Our aim is to develop a 
delivery system containing bacteriophages and/or derived enzymes for a targeted treatment of otitis 
media. To achieve this purpose, samples from the middle ear fluid of children with otitis media have 
been collected and the presence of the main otopathogens assessed by culture methods. To date, S. 
pneumoniae was the most frequent pathogen detected (44.1%), followed by M. catarrhalis (38.2%) 
and H. influenzae (14.7%). In these samples the presence of other bacterial species was also observed. 
In different attempts, using nasopharyngeal, middle ear fluid and wastewater treatment effluent 
samples, we were not able to isolate any virulent phage against clinical isolates of S. pneumoniae, H. 
influenzae and M. catarrhalis. Novel endolysins with predicted amidase and muramidase activity 
were identified in the genome of a S. pneumoniae virulent phage and in a H. influenzae prophage, 
respectively. The endolysin of S. pneumoniae (MSlys) was successfully cloned and expressed in 
Escherichia coli, in contrast to the H. influenzae lysin, which was not possible to express. Preliminary 
results of MSlys antibacterial activity showed reductions of 3 logarithmic units of R6st cells within 
2 hours, having potential to be used in the control of otitis media infections.  
